Transcripts

ResMed| (RMD) earnings call transcripts

Earnings call transcripts for ResMed|, with a summary, the guidance given, and what analysts pressed on.

Open RMD in Gloom →
  • Q4 2026 earnings call

    Management framed the year around core-market demand generation, portfolio focus and capital returns, while introducing formal FY27 revenue and EPS guidance.

    Aug 06, 2026Confident0.72